Athersys Inc. stem cell therapy for bowel disease fails to show ‘meaningful … – Crain’s Cleveland Business
Crain’s Cleveland BusinessThe results reflect patient data for eight weeks following cell therapy or placebo administration, Athersys said. Additional 16-week results, including data about the impact from a second round of dosing for a subset of patients, will be available …Athersys stem–cell therapy for bowel disease fails in studyReutersAthersys stem cell therapy disappoints in first … Continue reading